Estados financieros detallados de Rapid Micro Biosystems, Inc. (RPID): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Rapid Micro Biosystems, Inc. registró ingresos de $33.6M en el último ejercicio fiscal, con un CAGR de 5 años del 15.9%.
Márgenes de los últimos 12 meses: margen bruto 10.0%, margen operativo -141.5%, margen neto -145.6%.
Al precio actual de $1.12, RPID presenta beneficios negativos (P/E no significativo) y un ROE del -177.04%. La capitalización bursátil es de $51M.
Cuenta de Resultados (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $16.5M | $16.1M | $23.2M | $17.1M | $22.5M | $28.1M | $33.6M |
| Coste de Ventas | $16.7M | $24.1M | $31.0M | $25.7M | $28.0M | $28.2M | $26.0M |
| Beneficio Bruto | -$234000 | -$8.1M | -$7.7M | -$8.5M | -$5.5M | -$109000 | $7.6M |
| I+D | $5.4M | $6.5M | $9.8M | $12.9M | $12.8M | $14.6M | $13.6M |
| Generales y Administrativos | $13.0M | $15.9M | $29.7M | $41.8M | $38.3M | $35.2M | $34.8M |
| Gastos Operativos | $18.4M | $22.5M | $39.5M | $54.7M | $51.1M | $49.8M | $55.0M |
| Beneficio Operativo | -$18.6M | -$30.5M | -$47.2M | -$63.2M | -$56.6M | -$49.9M | -$47.4M |
| EBITDA | -$16.9M | -$32.0M | -$69.3M | -$58.5M | -$49.3M | -$43.5M | -$42.7M |
| Gastos por Intereses | $2.4M | $3.4M | $2.6M | 0 | 0 | 0 | $1.1M |
| Beneficio Antes de Impuestos | -$20.7M | -$36.9M | -$73.4M | -$61.4M | -$52.4M | -$46.9M | -$47.1M |
| Impuestos | $427000 | $134000 | $91000 | -$576000 | $31000 | $22000 | $40000 |
| Beneficio Neto | -$21.2M | -$37.1M | -$73.5M | -$60.8M | -$52.5M | -$46.9M | -$47.1M |
| BPA | $-0.53 | $-1.17 | $-1.88 | $-1.43 | $-1.22 | $-1.08 | $-1.05 |
| BPA Diluido | $-0.53 | $-1.17 | $-1.88 | $-1.43 | $-1.22 | $-1.08 | $-1.05 |
| Acciones en Circulación (Diluidas) | $39.7M | $38.7M | $41.5M | $42.5M | $43.0M | $43.6M | $44.7M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $7.8M | $11.3M | $8.0M | $8.1M |
| Beneficio Bruto | $2.3M | -$329000 | $371000 | $1.2M |
| Beneficio Operativo | -$11.4M | -$12.2M | -$13.9M | -$12.3M |
| EBITDA | -$10.3M | -$10.9M | -$12.9M | -$12.2M |
| Beneficio Neto | -$11.5M | -$12.5M | -$14.3M | -$12.9M |
| BPA | $-0.25 | $-0.28 | $-0.31 | $-0.27 |
| BPA Diluido | $-0.25 | $-0.28 | $-0.31 | $-0.27 |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $12.5M | $30.1M | $178.4M | $27.1M | $24.3M | $16.9M | $20.0M |
| Inversiones a Corto | 0 | $15.0M | $15.1M | $81.6M | $67.8M | $33.8M | $18.3M |
| Cuentas por Cobrar | $4.9M | $5.8M | $5.6M | $5.5M | $5.6M | $7.5M | $3.3M |
| Inventario | $5.8M | $9.0M | $15.7M | $21.2M | $20.0M | $20.2M | $17.6M |
| Activos Corrientes | $23.6M | $62.1M | $218.1M | $138.6M | $120.4M | $80.9M | $61.2M |
| Inmovilizado Material | $7.6M | $7.1M | $11.3M | $20.9M | $19.1M | $16.4M | $13.1M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $31.7M | $70.0M | $241.2M | $190.7M | $143.5M | $98.2M | $74.9M |
| Cuentas por Pagar | $3.2M | $4.5M | $3.9M | $5.4M | $2.0M | $2.5M | $4.1M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | $1.2M | 0 |
| Pasivos Corrientes | $10.5M | $15.5M | $18.2M | $19.1M | $19.0M | $17.6M | $18.5M |
| Deuda a Largo | $17.8M | $24.8M | 0 | 0 | 0 | 0 | $18.9M |
| Pasivos Totales | $32.4M | $45.2M | $20.2M | $26.5M | $25.5M | $22.8M | $41.6M |
| Reservas | -$204.5M | -$241.6M | -$315.1M | -$375.9M | -$428.4M | -$475.3M | -$522.4M |
| Patrimonio Neto | -$725000 | $24.8M | $221.0M | $164.2M | $118.0M | $75.4M | $33.2M |
| Deuda Total | $17.8M | $24.8M | 0 | $8.0M | $7.3M | $6.2M | $23.9M |
| Deuda Neta | $5.3M | -$20.3M | -$193.5M | -$100.7M | -$84.7M | -$44.6M | -$14.4M |
| Capital Circulante | $13.1M | $46.6M | $200.0M | $119.5M | $101.4M | $63.4M | $42.7M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $18.9M | $20.0M | $13.8M | $14.7M |
| Activos Totales | $84.4M | $74.9M | $62.4M | $58.5M |
| Pasivos Totales | $40.1M | $41.6M | $42.0M | $40.7M |
| Patrimonio Neto | $44.3M | $33.2M | $20.4M | $17.7M |
| Deuda Total | $24.1M | $23.9M | $23.7M | $23.5M |
Flujo de Caja (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$21.2M | -$37.1M | -$73.5M | -$60.8M | -$52.5M | -$46.9M | -$47.1M |
| Amortizaciones | $1.5M | $1.5M | $1.5M | $2.8M | $3.1M | $3.4M | $3.3M |
| Compensación en Acciones | $473000 | $533000 | $1.8M | $4.0M | $4.8M | $3.9M | $4.0M |
| Cambio en Capital Circulante | -$2.1M | -$1.1M | -$8.0M | -$5.3M | $555000 | -$4.8M | $6.1M |
| Flujo de Caja Operativo | -$21.1M | -$31.0M | -$55.0M | -$58.5M | -$45.1M | -$44.2M | -$31.1M |
| Inversiones (CapEx) | -$1.7M | -$690000 | -$3.2M | -$6.7M | -$1.8M | -$1.4M | -$850000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$22.8M | -$31.7M | -$58.2M | -$65.3M | -$46.9M | -$45.5M | -$31.9M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$9.1M | -$3.2M | -$15.1M | -$12.7M |
| Inversiones (CapEx) | -$73000 | -$92000 | -$394000 | $223000 |
| Flujo de Caja Libre | -$9.1M | -$3.3M | -$15.5M | -$12.5M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.1M | $627000 | $1.2M | $1.3M |
Crecimiento y Márgenes (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | -2.6% | +44.5% | -26.3% | +31.4% | +24.6% | +19.7% |
| Crecimiento Beneficio Neto (anual) | | -75.1% | -98.3% | +17.3% | +13.7% | +10.6% | -0.5% |
| Crecimiento BPA (anual) | | -120.8% | -60.7% | +23.9% | +14.7% | +11.5% | +2.8% |
| Cambio en Acciones (anual) | | -2.5% | +7.2% | +2.4% | +1.3% | +1.3% | +2.5% |
| Crecimiento FCF (anual) | | -38.7% | -83.6% | -12.2% | +28.1% | +3.0% | +29.9% |
| Margen Bruto | -1.4% | -50.2% | -33.3% | -49.8% | -24.4% | -0.4% | 22.7% |
| Margen Operativo | -112.9% | -190.0% | -203.3% | -369.0% | -251.2% | -178.0% | -141.1% |
| Margen EBITDA | -102.2% | -199.0% | -298.1% | -341.7% | -219.1% | -155.1% | -127.3% |
| Margen Neto | -128.2% | -230.6% | -316.5% | -354.9% | -233.0% | -167.2% | -140.3% |
| Margen FCF | -138.3% | -197.1% | -250.4% | -381.1% | -208.4% | -162.3% | -95.0% |
| Tasa Impositiva Efectiva | -2.1% | -0.4% | -0.1% | 0.9% | -0.1% | -0.0% | -0.1% |
Datos por Acción (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.58 | $-0.82 | $-1.40 | $-1.54 | $-1.09 | $-1.04 | $-0.71 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $39.7M | $38.7M | $41.5M | $42.5M | $43.0M | $43.6M | $44.7M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -177.04% |
| Rentabilidad sobre capital invertido | -119.49% |
| Rentabilidad sobre activos | -87.60% |
| Margen bruto | 10.03% |
| Margen operativo | -141.45% |
| Margen neto | -145.56% |
Salud financiera
| Deuda / Patrimonio | 1.32 |
| Ratio corriente | 2.55 |
Ratios Clave (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -40.38 | -18.29 | -5.66 | -0.79 | -0.61 | -0.83 | -2.76 |
| P/VC | -1170.67 | 33.34 | 2.00 | 0.29 | 0.27 | 0.52 | 3.90 |
| P/V | 51.40 | 51.47 | 18.99 | 2.80 | 1.41 | 1.40 | 3.86 |
| Margen Bruto | -1.4% | -50.2% | -33.3% | -49.8% | -24.4% | -0.4% | 22.7% |
| Margen Operativo | -112.9% | -190.0% | -203.3% | -369.0% | -251.2% | -178.0% | -141.1% |
| Margen Neto | -128.2% | -230.6% | -316.5% | -354.9% | -233.0% | -167.2% | -140.3% |